CONCORD BIOTECH
|
The Current P/E Ratio of CONCORD BIOTECH is 52.88.
Share Price | ₹1,659.5 | Apr 01,2025 |
Market Cap | ₹17,357.8 Cr | |
Earnings-TTM | ₹328.2 Cr | TTM-Consolidated Results |
Price/Earnings | 52.88x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of CONCORD BIOTECH
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹17,357.8 Cr] as on Apr 01,2025
(/) Earnings [ ₹328.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 52.88x ]
Thus, for CONCORD BIOTECH , the investors are currently willing to pay 52.88 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of CONCORD BIOTECH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of CONCORD BIOTECH over the last five years.
Historical PE (Price/Earnings) ratio chart of CONCORD BIOTECH
PE Ratio Performance Analysis for CONCORD BIOTECH
- CONCORD BIOTECH 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 10.34x.
- CONCORD BIOTECH 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CONCORD BIOTECH 's p/e ratio peaked in Mar2024 at 51.68x.
- CONCORD BIOTECH 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does CONCORD BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
CONCORD BIOTECH | 328.24 | 52.88 | 17,357.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.45 | 407,155.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 71.26 | 147,295.0 |
CIPLA LTD | 5,000.43 | 23.33 | 116,664.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 57.83 | 107,678.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.71 | 96,162.6 |
MANKIND PHARMA LTD | 2,050.73 | 49.43 | 101,358.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.23 | 88,297.0 |
LUPIN LTD | 2,892.10 | 30.88 | 89,322.4 |
AUROBINDO PHARMA LTD | 3,500.25 | 18.83 | 65,912.3 |
ABBOTT INDIA LTD | 1,334.46 | 48.26 | 64,397.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs CONCORD BIOTECH 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.71x |
Max industry PE | 71.26x |
Median industry PE | 35.45x |
Average industry PE | 38.64x |
You may also like the below Video Courses